Robert Foster

ROBERT FOSTER, Chairman, Chief Executive Officer and a Director of
Isotechnika Inc., has been a director and officer of Isotechnika since
he founded the company in 1993. He brings to the company expertise
acquired through his education, his teaching responsibilities, and the
publication of over 125 scientific papers, articles and book chapters
focused on drug development and analysis. He has received numerous
grants and awards for both pharmaceutical research and teaching.
Additionally, Dr. Foster holds several pharmaceutical patents. Dr.
Foster was a tenured Associate Professor (clinical pharmacokinetics) in
the Faculty of Pharmacy and Pharmaceutical Sciences at the University of
Alberta for a period of approximately nine years. During this time, he
also served for two years as Chairman of Pharmacy Practice and numerous
other university committees. He currently remains as Adjunct Full
Professor in the faculty. Dr. Foster was also Medical Staff, Scientific
and Research Associate in the Department of Laboratory Medicine at the
Walter C. Mackenzie Health Sciences Centre from 1990 to 1994. Dr. Foster
has served on the Alberta Science and Research Authority Technology
Commercialization Task Force, and was a member of the Board of
Management for the Alberta Research and Science Authority. Dr. Foster
also served on the Premier’s Advisory Council on Health. In addition, he
has served on other companies’ Boards, is a member of numerous
scientific associations, a board member of BioAlberta, on the Board of
Management of the Alberta Economic Development Authority, and has served
as a consultant with many pharmaceutical companies. Since founding the
company in 1993, Dr. Foster has assembled the core scientific and
business team that has led the company to its current successes. Dr.
Foster, along with the other senior executive team members, has raised
close to $200 million through various equity financings in North America
and abroad. As Chairman and CEO of Isotechnika Inc., Dr. Foster and his
team have taken Isotechnika Inc. to become one of Canada’s leading
biotechnology companies, listed on the TSX.